The (ROM) for each Bethesda category The 2023 updates to the system How it compares to the TIRADS system for imaging Let me know which area you'd like to explore further.
It categorizes thyroid nodules into six distinct groups based on the fine needle aspiration cytology (FNAC) results, each associated with a specific risk of malignancy (RoM) and recommended management: The Bethesda System for Reporting Thyroid Cytop...
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more Bethesda System for Reporting Thyroid Cytopathology Defin The (ROM) for each Bethesda category The 2023
The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) arose from a need to standardize how doctors report thyroid biopsy results, moving away from vague, subjective language towards a uniform system that helps predict cancer risk. The Story of the Bethesda System AI responses may include mistakes
Before this system was finalized (originally around 2010 and updated in 2023), different laboratories used different terms to describe thyroid fine-needle aspiration (FNA) samples, causing confusion for clinicians. The Bethesda System was developed through an NIH-sponsored conference to create a common language.
It ensures that a "suspicious" result means the same thing, regardless of which lab processed it.